Purine Compunds as HSP90 Protein Inhibitors for the Treatment of Cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090181989A1
SERIAL NO

12394891

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of formula (I) are inhibitors of HSP90, and of utility in the treatment of, for example, cancers:is hydrogen, or a substituent as defined in the specification.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CANCER RESEARCH TECHNOLOGY LTDLONDON LONDON LONDON
VERNALIS (R&D) LTD100 BERKSHIRE PLACE WHARFEDALE ROAD WINNERSH RG41 5RD
THE INSTITUTE OF CANCER RESEARCHROYAL CANCER HOSPITAL 123 OLD BROMPTON ROAD LONDON SW7 3RP

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BARRIL-ALONSO, Xavier Barcelona , ES 7 23
BROUGH, Paul Andrew Berkshire , GB 6 4
DRYSDALE, Martin Berkshire , GB 11 16

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation